When you think of dangerous animals, the ones that typically spring to mind have teeth or claws. But what about wings and a proboscis?
In many countries, mosquitoes are nothing more than a nuisance. But in others, they spread tropical diseases that kill at least 700,000 people a year — more than any other animal, according to estimates from the World Health Organization. Unfortunately, they’re likely to get deadlier. As greenhouse-gas emissions make our planet hotter and wetter, disease-spreading mosquitoes are thriving.
With nations in South America battling some of the worst outbreaks of mosquito-borne disease in decades, the case of a British woman who caught dengue while on holiday in France last summer has sparked warnings about similar outbreaks in countries where insect-carried pestilence hasn’t previously been endemic. Climate change is making tropical diseases everybody’s problem.
Judging by what’s happening in Latin America, 2023 could be even worse. In a WHO press conference at the start of April about the worrying dengue and chikungunya (a related virus spread by the same mosquitoes) epidemics there, Raman Velyayudhan, head of the WHO global program on the control of neglected tropical diseases, said that trend could continue around the world this year.
It’s not just mosquitos that are enjoying the warmer temperatures, but a whole host of disease-spreading vectors, including ticks (which carry encephalitis and Lyme disease) and even freshwater snails (schistosomiasis). Higher temperatures and increased humidity and rainfall boost the biting proclivities, reproductive rates and spatial distribution of these hosts.
It’s a problem that’s top of mind for the Wellcome Trust, a global charitable foundation focusing on health. It’s investing in research around climate-change and vector-borne diseases, and has provided £22.7 million ($28 million) for 24 research teams developing digital tools to better predict when infectious disease outbreaks might occur. One such project is E-Dengue in Vietnam, designed to help health systems prepare for dengue outbreaks up to two months in advance by collating local data. Dung Phung, the lead scientist on the project, said that currently dengue prevention and control is mostly reactive, limiting the effectiveness of measures to combat its spread. An early warning system would help address that.
There's been some progress with vaccines. Nigeria and Ghana have provisionally approved a new malaria vaccine developed by scientists at the University of Oxford, and Japanese drugmaker Takeda Pharmaceutical Co.’s dengue shot is being steadily rolled out around the world.
Another promising tool is a bacteria called Wolbachia. Found in about 50 percent of insects, it’s been shown to outcompete viruses like dengue, Zika and chikungunya in yellow fever mosquitoes, making them less likely to pass on the disease to humans. One study in Indonesia showed that introducing mosquitoes infected with Wolbachia reduced dengue cases by 77 percent. The method is now being rolled out nationwide for the first time in Brazil.
But early warning systems and virus-blocking bacteria won't be magic bullets alone. “The combination of both is what is going to drive the change,” Felipe Colón-González, technology lead at the Wellcome Trust, told me. “To be able to apply Wolbachia more effectively, you need to identify hotspots, and it's through the usage of early warning systems and risk metrics that you can identify them.”
There are plenty of challenges ahead. Colón-González stressed the need for better collaboration between researchers and policy makers, more data collection, and sharing and talent development, especially in low-income countries, which bear the brunt of climate change and tropical disease.
With COVID still fresh on our minds, the obvious question is: “What’s the pandemic risk?” The answer to that is shrouded in uncertainty — viruses are unpredictable — but Diana Rojas Alvarez, co-lead of the WHO’s global arbovirus initiative, noted in a press conference that whenever a vector is present and there is a susceptible population, then there is a risk of large epidemics, if not a pandemic.
A widespread outbreak, especially of a disease that hasn’t historically been endemic, would certainly be enough to overwhelm even the health systems of high-income countries, as the COVID-19 pandemic demonstrated with tragic consequences. As Colón-González says: “If we don’t pay attention, it will happen again.”
Lara Williams is a Bloomberg Opinion columnist covering climate change. Views are personal, and do not represent the stand of this publication.
Credit: Bloomberg
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
